Ingresar
Argentinian manufacturers complete training to improve regional vaccine production
By Estudio Chaloupka
A group of vaccine manufacturers from Argentina and Brazil have become the first to receive technology transfer training in mRNA vaccines at Afrigen, South Africa, as part of a Pan American Health Organization (PAHO) platform to advance the availability of key medical health technologies in the region.This training is a key component of the Regional Platform to Advance the Manufacturing of COVID-19 Vaccines and other Health Technologies in the Americas, which is a collaboration between PAHO, its Member States and regional partners, aims to improve local production capacities to address the inequities in access to essential medicines and other health technologies faced by countries in the region during the COVID-19 pandemic.
During the training, which took place from 7 to 9 March 2022 at the Afrigen’s laboratory in Cape Town, scientists from Sinergium Biotech in Argentina, and the Bio-Manguinhos Institute of Technology in Brazil learned about Afrigen’s manufacturing processes, including the formulation of lipid nanoparticles, data analytics, and the production and control of vaccines using mRNA technology.
“The benefit of this training is enormous,” Sotiris Missailidis, Research and Development Director at Bio-Manguinhos said. “It enables countries to develop and produce their own mRNA vaccines and supply these where they are most needed.”
“mRNA technology is a huge field to explore,” added German Sanchez Alberti, Project Manager at Sinergium. “The technology transfer will enable companies to manufacture vaccines not only for COVID-19 but for influenza and other respiratory viruses.”
The Latin America and the Caribbean region imports 10 times more pharmaceuticals than it exports, leaving it vulnerable to fluctuations in global supply, particularly during emergencies.
Severe shortages of COVID-19 vaccines were a wake-up call in the past year, highlighting the urgent need to rapidly increase regional production of vaccines.
Estudio Chaloupka
Estudio Chaloupka Industrial Property is a professional firm specialized in Intellectual Property, existing as of more than 50 years (under different names), with a staff of professionals with a high level of technical and legal expertise in trademarks, patents, models and industrial designs, copyright, software, licensing, domain names and litigation.
The firm provides its clients - pertaining to the fields of pharmaceuticals, chemicals including agrochemicals, banking, luxury goods, equipment and supplies for the oil industry, footwear, garments, food and drinks, hotels- with a complete range of intellectual property services not only in Argentina but also throughout the world.
Our professional team is committed to providing clients with high quality services, tailored to their particular needs, allowing them to achieve their professional and business goals.
